Award recordCONTRACT

IMPEL PHARMACEUTICALS INC

PIID 36C24924F0083· VHA· 249-NETWORK CONTRACT OFFICE 9 (36C249)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $0 net obligations· UEI VGX8L65CX5A3· WA

Description

4ML TRUDHESA

First action · last action
2024-03-04 · 2024-03-14
Transactions
2
First transaction's obligation
$3,784
Base + all options value (sum of deltas)
$0
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79722D0182
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$3,784$0Base award · 2024-03-04 · this action $3,784 · running total $3,784Modification P00001 · 2024-03-14 · this action -$3,784 · running total $0
  • Base2024-03-04+$3,784= $3,784
  • Mod P000012024-03-14-$3,784= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-03-04+$3,784$3,7844ML TRUDHESA
Mod P00001· OTHER ADMINISTRATIVE ACTION2024-03-14−$3,784$04ML TRUDHESA

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI VGX8L65CX5A3)

AwardOffice · PSC / listingNet obligationsFY
36C25224F0185252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$3,784FY2024
36C25224F0068252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$3,627FY2024
36C24924F0025249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$3,694FY2024
36F79722D0182NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36F79722D001ENAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
VA26113P2908261-NETWORK CONTRACT OFFICE 21 · AN92 · R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)$3,995FY2013

Other recipients under 6505 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24926N0676AMICUS THERAPEUTICS US, LLC249-NETWORK CONTRACT OFFICE 9 (36C249)$68,519FY2026
36C24926N0651BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$378,650FY2026
36C24926N0658BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0590BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0589BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24924F0083_3600_36F79722D0182_3600 · retrieved 2026-09-26.